Article: Uroplasty gets approvable letter for SUI bulking agent.

Uroplasty gets approvable letter for SUI bulking agent

By KAREN YOUNG

Medical Device Daily Staff Writer

Uroplasty (Minnetonka, Minnesota) reported last week that it has received an approvable letter for its pre-market application (PMA) from the FDA for what would be the company?s third product on the market in the U.S., Macroplastique Implants, one of what is known as ?bulking agents? for stress urinary incontinence (SUI) in females.

It would add to its I-STOP Mid-Urethral Sling, also for SUI, it said.

?We?re thrilled around here,? David Kaysen, president/CEO of Uroplasty, told Medical Device Daily. ?It was a long time coming. ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!